on the basis of these results it can be concluded that in melanoma the combination of daily administration of interferon and vinblastine is not effective , whereas in renal cell cancer interferon and vinblastine treatment given three times a week seems to be favorable .
C0007134
renal cell cancer
C0021747
interferon